Filtered By:
Specialty: Medical Devices
Cancer: Cancer
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 23 results found since Jan 2013.
J & J ’ s Cerenovus wins FDA nod for Embotrap II revascularization device
Johnson & Johnson‘s (NYSE:JNJ) Cerenovus said today it won FDA 510(k) clearance for the Embotrap II revascularization device.
The Irvine, Calif.-based J&J division said that the device is designed to quickly restore natural blood flow by retrieving emboli within the vasculature of the brain, using minimal compression to protect against further complications.
Approval of the device came based on data from the Arise II study, in which investigators reported being able to restore blood flow in 80% of patients treated within three passes, and in approximately 50% within a single pass. More than 66% of patients ...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Neurological Regulatory/Compliance Vascular cerenovus johnsonandjohnson Source Type: news
AliveCor raises $30m, launches Kardia Pro platform in U.S.
AliveCor said today that it landed $30 million in a series D funding round and that it released its artificial intelligence-enabled Kardia Pro platform in the U.S.
The company’s platform enables doctors to remotely monitor their patients for early signs of atrial fibrillation, a common cardiac arrhythmia.
“Heart disease is the No. 1 cause of death in the United States, claiming more lives than all forms of cancer combined. To manage heart disease and stroke risk, leading cardiologists want to see more than just ECGs from their patients,” CEO Vic Gundotra said in prepared remarks. “Kardia Pro tracks important meas...
Source: Mass Device - March 16, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Funding Roundup Patient Monitoring Wall Street Beat AliveCor Source Type: news
Artificial Intelligence in Medicine: Hope or Hype?
The use of Artificial Intelligence (AI) is on the rise in the technology sector and has become a buzz-worthy topic in many corners of our digital world. The application of AI in the medical field holds great promise for improving patient health, but will doctors and patients feel comfortable using it? Young startups have begun leveraging this technology to prove better health outcomes, but there's still a lot to do before we'll see AI used pervasively in the clinic.
Current Landscape
To date, the sweet spot in healthcare AI has been pairing algorithms with structured exercises in reading patient data and medical images to...
Source: MDDI - January 3, 2018 Category: Medical Devices Authors: Brian Scogland Tags: Software Source Type: news
Korean JLK Inspection launches AI-powered imaging diag system
Korean JLK Inspection said yesterday that it launched its AIHub artificial intelligence-powered medical image diagnostics platform.
The newly launched AIHub system is designed to analyze images from a number of different imaging modalities, including magnetic resonance imaging, computed tomography, X-ray and mammography, the Seoul-based company said.
JLK Inspection claims the system can detect and monitor for more than 30 medical conditions in 14 regions of the body. The company added that the system is focused on brain diseases and conditions including ischemic stroke, hemorrhagic stroke, brain aneurysm and Alzheimer̵...
Source: Mass Device - December 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Imaging Software / IT jlkinspection Source Type: news
Cleveland Clinic Unveils Top 10 Medical Innovations For 2015
Cleveland Clinicrecently announced its 9th annual list of Top 10 Medical Innovations that are likely to have major impact on improving patient care in 2015. The list includes a mobile stroke ambulance, fast, painless blood-testing, and a novel intra-operative radiation approach for breast cancer.
Source: Medical Design Online News - October 31, 2014 Category: Medical Equipment Source Type: news
Google To Develop Nanoparticle Pills With Diagnostic Wristband
Take a nanoparticle pill, then monitor health data on a wristband detector. This is the vision behind Google’s new system for the preventative diagnosis of cancer, stroke, heart attacks, and other diseases.
Source: Medical Design Online News - November 3, 2014 Category: Medical Equipment Source Type: news
MassDevice.com +3 | The top 3 medtech stories for August 17, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. CooperSurgical pays $47m for IVF screener Reprogenetics
Cooper Cos. CooperSurgical subsidiary acquired in-vitro fertilization screening company Reprogenetics for nearly $47 million.
Livingston, N.J.-based Reprogenetics offers pre-implantation genetic screening and diagnosis for in vitro fertil...
Source: Mass Device - August 17, 2015 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 11, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Stimwave wins Australian regulatory nod for Freedom SCS
Stimwave Technologies said late last week it won approval from the Australian Therapeutic Goods Administration for its Freedom spinal cord stimulation system, and launched ...
Source: Mass Device - April 11, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
MassDevice.com +5 | The top 5 medtech stories for May 19, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. The key components of a well-designed wearable: Sense, analyze, act
One of the earliest uses of a wearable technology was recorded during Emperor Nero’s rule over the Roman Empire from 54 to 68 AD. A brutal leader, the empero...
Source: Mass Device - May 19, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
How Genomic Research is Changing Heart Care
Genomic testing is most frequently associated with cancer testing, but this area of research is beginning to make an impact on cardiovascular care. A recent scientific statement by the American Heart Association shined a spotlight on how the expressed genome can potentially be used to diagnose diseases and predict who will develop diseases such as coronary artery disease (CAD), stroke, heart failure, and arrhythmias.
According to the statement, scientists now have the ability to address disease at many levels that were inaccessible during the past century. This includes the genome, transcriptome, epigenome, proteome, metab...
Source: MDDI - October 27, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Cardiovascular Source Type: news
3 Reasons TAVR Will Continue to Prosper
The transcatheter aortic valve replacement (TAVR) market has already seen rapid growth, and today represents a $3 billion market globally. But the leading TAVR companies say the current technology and approved indications barely scratches the surface in terms of the true growth potential of the space.
Michael Mussallem, CEO of Edwards Lifesciences, told J.P. Morgan Healthcare Conference attendees on Monday that the global TAVR market is expected to exceed $5 billion by 2021, and that number does not include certain indications that are currently being explored, like treatment for patients with asymptomatic aortic stenosi...
Source: MDDI - January 9, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news
The Biomarker Disruptor
Would you rather get a biopsy or a blood test to check for prostate cancer?
Quanterix chairman/CEO Kevin Hrusovsky said with the help of his company's latest product, the SR-X Ultra-Sensitive Biomarker Detection System, a simple blood test could replace, or complement, invasive diagnostic procedures. Using digital technology, the SR-X can detect cancer, neurological disorders, inflammatory and infectious diseases, and heart events months or even years earlier, and less invasively, than existing technology.
Using Quanterix's single molecule array (Simoa) science, which is similar to a digital enzyme-linked immunosorbent ...
Source: MDDI - January 16, 2018 Category: Medical Devices Authors: Heather R. Johnson Tags: IVD Source Type: news
SQI Test Detects Heart Attack Before It Happens
There isn't a shortage in the number of companies developing tests for cancer detection. However, it’s a far different story when it comes to diagnostics for cardiovascular diseases. Two companies are bringing a huge spotlight to the space and have created a test that can predict a cardiac event.
SQI Diagnostics and Predictive Health Diagnostics (PHD) announced the validation, commercial transition, and development of the PULS Cardiac Test.
"This is a serum blood test for all those people who look healthy and have normal lipids, yet still go on to have a heart attack," Douglas Harrington, CEO of PHD, told MD+DI. "...
Source: MDDI - February 28, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular IVD Source Type: news
Medtronic inks 5-year partnership with Lehigh Valley Health Network
Medtronic (NYSE:MDT) today announced a five-year strategic partnership with Lehigh Valley Health Network looking to develop value-based solutions for patients within the network.
The LVHN serves a total of eight hospitals across seven counties in Northeastern Pennsylvania, Fridley, Minn.-based Medtronic said.
The healthcare network’s partnership with Medtronic will aim to create programs for more than 70 major medical conditions with goals of reducing cost by $100 million and improving outcomes for as many as 500,000 patients.
“This agreement is exciting not only for Medtronic and LVHN, but also for the health...
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Hospital Care Medtronic Source Type: news
Medtronic Finds Another Value-Based Care Partner
Dublin, Ireland-based Medtronic continues to lead the charge toward value-based care with a new five-year strategic partnership with Lehigh Valley Health Network (LVHN), an eight-hospital network in Northeastern Pennsylvania. The partnership is aimed at developing innovative, sustainable, and integrated value-based solutions to improve healthcare outcomes for LVHN's patients.
The partnership will create programs that span more than 70 major medical conditions, with the goal of positively impacting as many as 500,000 patients and reducing their cost of care by $100 million.
The organizations said the partnership will leve...
Source: MDDI - February 28, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Source Type: news
